FR2480779B2
(fr)
|
1979-08-30 |
1986-07-18 |
Anvar |
Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur
|
US6096879A
(en)
|
1978-12-18 |
2000-08-01 |
Institut Pasteur |
Nucleotide sequence comprising the genome of hepatitis B virus, nucleotide sequence coding the surface antigen of the hepatitis B virus, vectors containing the nucleotide sequences, process for the preparation thereof, and antigen obtained thereby
|
US6268122B1
(en)
|
1978-12-22 |
2001-07-31 |
Biogen, Inc. |
Recombinant DNA molecules and their method of production
|
US5196194A
(en)
|
1979-05-24 |
1993-03-23 |
The Regents Of The University Of California |
Vaccines containing Hepatitis B S-protein
|
EP0299242A3
(en)
|
1987-06-22 |
1989-01-25 |
Medico Labs Ag |
Heterologous viral peptide particle immunogens
|
US6297048B1
(en)
|
1992-02-04 |
2001-10-02 |
Chiron Corporation |
Hepatitis therapeutics
|
US6174666B1
(en)
|
1992-03-27 |
2001-01-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of eliminating inhibitory/instability regions from mRNA
|
US5595739A
(en)
|
1993-05-07 |
1997-01-21 |
Abbott Laboratories |
Hepatitis B virus mutants, reagents and methods for detection
|
GB9401987D0
(en)
|
1994-02-02 |
1994-03-30 |
Imperial College |
Modified nucleic acid
|
US7732423B2
(en)
|
1994-04-27 |
2010-06-08 |
Institut Pasteur |
Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis
|
WO1996012027A1
(en)
|
1994-10-18 |
1996-04-25 |
Scottish Crop Research Institute |
Method of producing a chimeric protein
|
JPH11508766A
(ja)
|
1995-06-20 |
1999-08-03 |
ザ・ジェネラル・ホスピタル・コーポレイション |
B型肝炎複製の抑制
|
ZA973367B
(en)
|
1996-04-19 |
1997-11-18 |
Innogenetics Nv |
Method for typing and detecting HBV.
|
JP2001500012A
(ja)
|
1996-09-03 |
2001-01-09 |
ザ ジェネラル ホスピタル コーポレーション |
ウイルス複製の阻害
|
EP0919568A1
(en)
|
1997-12-01 |
1999-06-02 |
Sorin Diagnostics S.r.l. |
Escape mutant of the surface antigen of hepatitis B virus
|
FR2775435B1
(fr)
|
1998-02-27 |
2000-05-26 |
Bioalliance Pharma |
Nanoparticules comprenant au moins un polymere et au moins un compose apte a complexer un ou plusieurs principes actifs
|
US6787142B2
(en)
|
2001-04-30 |
2004-09-07 |
Government Of Republic Of Singapore |
Mutant human hepatitis B viral strain and uses thereof
|
NZ508890A
(en)
|
1998-06-19 |
2004-04-30 |
Government Of The Republic Of Singapore |
A mutant human hepatitis B viral strain and used thereof
|
HUP0103258A3
(en)
|
1998-06-19 |
2003-10-28 |
Government Of The Republic Of |
A vaccine-induced hepatitis b viral strain and uses thereof
|
CA2337680A1
(en)
|
1998-07-13 |
2000-01-20 |
Expression Genetics, Inc. |
Polyester analogue of poly-l-lysine as a soluble, biodegradable gene delivery carrier
|
US7067247B2
(en)
|
2000-03-31 |
2006-06-27 |
Ortho-Clinical Diagnostics, Inc. |
Hepatitis B virus surface protein
|
AU6616301A
(en)
|
2000-06-22 |
2002-01-02 |
Celltech Pharmaceuticals Ltd |
Modification of hepatitis b core antigen
|
US7202354B2
(en)
|
2001-03-30 |
2007-04-10 |
Abbott Laboratories |
Hepatitis B virus surface antigen mutant and methods of detection thereof
|
WO2004017945A1
(en)
|
2002-07-29 |
2004-03-04 |
Nanodel Technologies Gmbh |
Nanoparticles for dna administration to a target organ
|
ATE546156T1
(de)
|
2002-12-10 |
2012-03-15 |
Sanofi Pasteur Biologics Co |
Stabilisierte immunogene chimäre hbc-partikel
|
US7727969B2
(en)
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
PL1711518T3
(pl)
*
|
2004-01-23 |
2010-06-30 |
St Di Richerche Di Biologia Molecolare P Angeletti S P A |
Nośniki szczepionek pochodzące od szympansich adenowirusów
|
CN101031569B
(zh)
|
2004-05-13 |
2011-06-22 |
艾科斯有限公司 |
作为人磷脂酰肌醇3-激酶δ抑制剂的喹唑啉酮
|
US7404969B2
(en)
|
2005-02-14 |
2008-07-29 |
Sirna Therapeutics, Inc. |
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
|
TWI382019B
(zh)
|
2005-08-19 |
2013-01-11 |
Array Biopharma Inc |
作為類鐸受體(toll-like receptor)調節劑之胺基二氮雜呯
|
TW201402124A
(zh)
|
2005-08-19 |
2014-01-16 |
Array Biopharma Inc |
作為類鐸受體(toll-like receptor)調節劑之8-經取代苯并氮雜呯
|
EP1783228A1
(en)
|
2005-11-08 |
2007-05-09 |
ETH Zürich |
Recombinant expression of multiprotein complexes using polygenes
|
WO2008005555A1
(en)
|
2006-07-07 |
2008-01-10 |
Gilead Sciences, Inc. |
Modulators of toll-like receptor 7
|
EP2057268B1
(en)
|
2006-08-14 |
2014-08-13 |
Postech Foundation |
A dna vaccine for curing chronic hepatitis b and a method of preparing same
|
KR100836745B1
(ko)
|
2007-01-31 |
2008-06-10 |
(주)두비엘 |
Hbv 백신 및 그의 제조 방법
|
EP2170888B1
(en)
|
2007-06-29 |
2015-04-22 |
Gilead Sciences, Inc. |
Purine derivatives and their use as modulators of toll-like receptor 7
|
US8138318B2
(en)
|
2007-09-13 |
2012-03-20 |
Abbott Laboratories |
Hepatitis B pre-S2 nucleic acid
|
CA2698812A1
(en)
|
2007-09-14 |
2009-03-19 |
Nitto Denko Corporation |
Drug carriers
|
DE102007062962A1
(de)
|
2007-12-21 |
2009-06-25 |
Siemens Healthcare Diagnostics Products Gmbh |
Neue Oberflächen-Protein-Mutante des Hepatitis B Virus HBV surface Antigen (HBsAg)
|
DK2238255T3
(da)
|
2007-12-27 |
2013-11-18 |
Univ Zuerich |
Replikationsdefekte arenavirusvektorer
|
KR101927291B1
(ko)
|
2008-07-08 |
2018-12-10 |
인사이트 홀딩스 코포레이션 |
인돌아민 2,3-디옥시게나아제의 억제제로서의 1,2,5-옥사디아졸
|
US8242106B2
(en)
|
2008-08-01 |
2012-08-14 |
Ventirx Pharmaceuticals, Inc. |
Toll-like receptor agonist formulations and their use
|
KR101687841B1
(ko)
|
2008-12-09 |
2016-12-19 |
길리애드 사이언시즈, 인코포레이티드 |
톨-유사 수용체의 조절제
|
WO2010120874A2
(en)
|
2009-04-14 |
2010-10-21 |
Chimeros, Inc. |
Chimeric therapeutics, compositions, and methods for using same
|
CN102471765B9
(zh)
*
|
2009-07-02 |
2016-07-27 |
莫茨制药有限及两合公司 |
显示出缩短的生物学活性的神经毒素
|
JP5897464B2
(ja)
*
|
2009-08-07 |
2016-03-30 |
トランジェーヌ、ソシエテ、アノニムTransgene S.A. |
Hbv感染を治療するための組成物
|
US10076570B2
(en)
*
|
2009-08-07 |
2018-09-18 |
Transgene S.A. |
Composition for treating HBV infection
|
US8524702B2
(en)
|
2009-08-18 |
2013-09-03 |
Ventirx Pharmaceuticals, Inc. |
Substituted benzoazepines as toll-like receptor modulators
|
CN102753542B
(zh)
|
2009-08-18 |
2016-01-20 |
文蒂雷克斯药品公司 |
作为t0ll样受体调节剂的取代的苯并氮杂*
|
KR101793300B1
(ko)
|
2009-10-22 |
2017-11-02 |
길리애드 사이언시즈, 인코포레이티드 |
특히 바이러스성 감염의 치료에 유용한 퓨린 또는 데아자퓨린의 유도체
|
KR101230913B1
(ko)
|
2009-11-06 |
2013-02-07 |
중앙대학교 산학협력단 |
나노입자-기반된 유전자 운반체
|
SG177025A1
(en)
|
2010-06-21 |
2012-01-30 |
Agency Science Tech & Res |
Hepatitis b virus specific antibody and uses thereof
|
US9186337B2
(en)
|
2010-02-24 |
2015-11-17 |
Oryzon Genomics S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with Hepadnaviridae
|
AU2011260961B9
(en)
|
2010-05-31 |
2015-02-26 |
Ono Pharmaceutical Co., Ltd. |
Purinone derivative
|
US8907053B2
(en)
|
2010-06-25 |
2014-12-09 |
Aurigene Discovery Technologies Limited |
Immunosuppression modulating compounds
|
KR101209266B1
(ko)
|
2010-06-30 |
2012-12-06 |
한국과학기술연구원 |
생분해성 및 온도 감응성 폴리포스파젠계 자성 고분자, 그의 제조 방법 및 용도
|
ES2616449T3
(es)
|
2010-10-01 |
2017-06-13 |
Ventirx Pharmaceuticals, Inc. |
Uso terapéutico de un agonista de TLR y terapia de combinación
|
WO2012045089A2
(en)
|
2010-10-01 |
2012-04-05 |
Ventirx Pharmaceuticals, Inc. |
Methods for the treatment of allergic diseases
|
UY33775A
(es)
|
2010-12-10 |
2012-07-31 |
Gilead Sciences Inc |
Inhibidores macrocíclicos de virus flaviviridae, composiciones farmacéuticas que los comprenden y sus usos
|
CA2823182C
(en)
|
2010-12-30 |
2016-02-23 |
Samyang Biopharmaceuticals Corporation |
Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof
|
BR112013017943A2
(pt)
|
2011-01-12 |
2018-12-18 |
Array Biopharma Inc |
benzoazepinas substituídas como moduladores receptores do tipo toll
|
MX348935B
(es)
|
2011-01-12 |
2017-07-03 |
Ventirx Pharmaceuticals Inc |
Benzoazepinas sustituidas como moduladores de receptores tipo toll.
|
US9238679B2
(en)
|
2011-02-11 |
2016-01-19 |
The Trustees Of The University Of Pennslyvania |
Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
|
PT2672992T
(pt)
|
2011-02-11 |
2020-07-27 |
Univ Pennsylvania |
Molécula de ácidos nucleicos codificando proteína nuclear do vírus da hepatite b e vacina compreendendo a mesma
|
EP2672991B1
(en)
|
2011-02-12 |
2017-07-19 |
Globeimmune, Inc. |
Yeast-based therapeutic for chronic hepatitis b infection
|
ME03782B
(me)
|
2011-04-08 |
2021-04-20 |
Janssen Sciences Ireland Unlimited Co |
Derivati pirimidina za tretman virusnih infekcija
|
US8691750B2
(en)
|
2011-05-17 |
2014-04-08 |
Axolabs Gmbh |
Lipids and compositions for intracellular delivery of biologically active compounds
|
EA028254B1
(ru)
|
2011-05-18 |
2017-10-31 |
Янссен Сайенсиз Айрлэнд Юси |
Хиназолиновые производные для лечения вирусных инфекций и дальнейших заболеваний
|
GB201108879D0
(en)
|
2011-05-25 |
2011-07-06 |
Isis Innovation |
Vector
|
WO2012168944A1
(en)
|
2011-06-08 |
2012-12-13 |
Aurigene Discovery Technologies Limited |
Therapeutic compounds for immunomodulation
|
TWI623618B
(zh)
*
|
2011-07-12 |
2018-05-11 |
傳斯堅公司 |
Hbv聚合酶突變體
|
DE102011080362A1
(de)
|
2011-08-03 |
2013-02-07 |
Robert Bosch Gmbh |
Elektrisches Kontaktelement mit Rastlanze für ein Steckergehäuse
|
US20140235643A1
(en)
|
2011-10-04 |
2014-08-21 |
Gilead Calistoga Llc |
Novel quinoxaline inhibitors of pi3k
|
KR101383324B1
(ko)
|
2011-11-10 |
2014-04-28 |
주식회사 종근당 |
신규한 유전자 전달용 조성물
|
US8945876B2
(en)
|
2011-11-23 |
2015-02-03 |
University Of Hawaii |
Auto-processing domains for polypeptide expression
|
PT2786996T
(pt)
|
2011-11-29 |
2016-11-07 |
Ono Pharmaceutical Co |
Cloridrato de derivado de purinona
|
WO2013083847A2
(en)
*
|
2011-12-09 |
2013-06-13 |
Institut Pasteur |
Multiplex immuno screening assay
|
CA2857344C
(en)
|
2011-12-21 |
2019-02-12 |
Novira Therapeutics, Inc. |
Hepatitis b antiviral agents
|
WO2013116562A1
(en)
|
2012-02-03 |
2013-08-08 |
Gilead Calistoga Llc |
Compositions and methods of treating a disease with (s)-4 amino-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile
|
IN2014MN01736A
(es)
|
2012-02-08 |
2015-07-10 |
Janssen R & D Ireland |
|
EP2822957A1
(en)
|
2012-03-07 |
2015-01-14 |
Aurigene Discovery Technologies Limited |
Peptidomimetic compounds as immunomodulators
|
RU2014143443A
(ru)
|
2012-03-29 |
2016-05-20 |
Ориджин Дискавери Текнолоджиз Лимитед |
Иммуномодулирующие циклические соединения
|
US20130267517A1
(en)
|
2012-03-31 |
2013-10-10 |
Hoffmann-La Roche Inc. |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
CA2865259A1
(en)
|
2012-03-31 |
2013-10-03 |
F. Hoffmann-La Roche Ag |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
IN2014MN02658A
(es)
|
2012-06-08 |
2015-08-21 |
Gilead Sciences Inc |
|
AR091279A1
(es)
|
2012-06-08 |
2015-01-21 |
Gilead Sciences Inc |
Inhibidores macrociclicos de virus flaviviridae
|
PT2861604T
(pt)
|
2012-06-08 |
2017-05-05 |
Gilead Sciences Inc |
Inibidores macrocíclicos de vírus flaviridae
|
AU2013276015B2
(en)
|
2012-06-11 |
2017-04-20 |
Xiamen University |
Polypeptides and antibodies for treating HBV infection and related diseases
|
IN2015MN00478A
(es)
|
2012-08-10 |
2015-09-04 |
Janssen Sciences Ireland Uc |
|
CA2884870C
(en)
|
2012-08-13 |
2022-03-29 |
Massachusetts Institute Of Technology |
Amine-containing lipidoids and uses thereof
|
SG10201605291WA
(en)
|
2012-08-28 |
2016-08-30 |
Janssen Sciences Ireland Uc |
Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
|
ES2610758T3
(es)
|
2012-08-28 |
2017-05-03 |
Janssen Sciences Ireland Uc |
Derivados de sulfamoílo bicíclicos condensados y su uso como medicamentos en el tratamiento de la hepatitis B
|
CN104603125A
(zh)
|
2012-09-10 |
2015-05-06 |
弗·哈夫曼-拉罗切有限公司 |
用于治疗和预防乙型肝炎病毒感染的6-氨基酸杂芳基二氢嘧啶
|
CA2885969C
(en)
|
2012-10-02 |
2021-04-06 |
Epitherapeutics Aps |
Substitued pyridine derivatives and compositions thereof useful as inhibitors of histone demethylases
|
CN104837840B
(zh)
|
2012-10-10 |
2017-08-08 |
爱尔兰詹森科学公司 |
用于治疗病毒感染及其他疾病的吡咯并[3,2‑d]嘧啶衍生物
|
KR101268466B1
(ko)
|
2012-11-12 |
2013-06-04 |
유병수 |
사축형 윈드 터빈
|
AU2013346793B2
(en)
|
2012-11-16 |
2018-03-08 |
Janssen Sciences Ireland Uc |
Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
|
US9604961B2
(en)
|
2012-12-06 |
2017-03-28 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
EP2934145B1
(en)
|
2012-12-19 |
2017-11-15 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
PE20151417A1
(es)
|
2012-12-21 |
2015-10-10 |
Quanticel Pharmaceuticals Inc |
Inhibidores de histona desmetilasa
|
NZ708864A
(en)
|
2012-12-21 |
2016-09-30 |
Gilead Calistoga Llc |
Substituted pyrimidine aminoalkyl-quinazolones as phosphatidylinositol 3-kinase inhibitors
|
US9029384B2
(en)
|
2012-12-21 |
2015-05-12 |
Gilead Calistoga, LLC. |
Phosphatidylinositol 3-kinase inhibitors
|
KR102300861B1
(ko)
|
2013-02-21 |
2021-09-10 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
바이러스 감염의 치료를 위한 2-아미노피리미딘 유도체
|
US9650339B2
(en)
|
2013-02-27 |
2017-05-16 |
Gilead Sciences, Inc. |
Inhibitors of histone demethylases
|
HUE034820T2
(en)
|
2013-02-28 |
2018-02-28 |
Janssen Sciences Ireland Uc |
Sulphamoyl arylamides and their use as medicaments for the treatment of hepatitis B
|
US8993771B2
(en)
|
2013-03-12 |
2015-03-31 |
Novira Therapeutics, Inc. |
Hepatitis B antiviral agents
|
EP2968282B1
(en)
|
2013-03-12 |
2018-05-09 |
Celgene Quanticel Research, Inc. |
Histone dementhylase inhibitors
|
RU2015143517A
(ru)
|
2013-03-13 |
2017-04-19 |
Дженентек, Инк. |
Пиразолсодержащие соединения и их применения
|
CN104043120B
(zh)
|
2013-03-13 |
2017-05-31 |
南京赛威信生物医药有限公司 |
乙型肝炎疫苗
|
JP2016513971A
(ja)
|
2013-03-14 |
2016-05-19 |
アルトラバックス インコーポレイテッド |
B型肝炎ウイルスワクチン
|
US9133166B2
(en)
|
2013-03-14 |
2015-09-15 |
Quanticel Pharmaceuticals, Inc. |
Histone demethylase inhibitors
|
PL2970211T3
(pl)
|
2013-03-15 |
2018-01-31 |
Quanticel Pharmaceuticals Inc |
Inhibitory demetylazy histonowej
|
US9308236B2
(en)
|
2013-03-15 |
2016-04-12 |
Bristol-Myers Squibb Company |
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
|
EA027068B1
(ru)
|
2013-04-03 |
2017-06-30 |
Янссен Сайенсиз Айрлэнд Юси |
Производные n-фенилкарбоксамида и их применение в качестве лекарственных препаратов для лечения гепатита b
|
AU2014251247A1
(en)
*
|
2013-04-08 |
2015-11-05 |
Medimmune, Llc |
Vaccine composition and method of use
|
US20140329889A1
(en)
|
2013-05-03 |
2014-11-06 |
The Regents Of The University Of California |
Cyclic di-nucleotide induction of type i interferon
|
EA201592126A1
(ru)
|
2013-05-17 |
2016-05-31 |
Ф. Хоффманн-Ля Рош Аг |
6-мостиковые гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b
|
JO3603B1
(ar)
|
2013-05-17 |
2020-07-05 |
Janssen Sciences Ireland Uc |
مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
|
WO2014184365A1
(en)
|
2013-05-17 |
2014-11-20 |
Janssen R&D Ireland |
Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
WO2014201409A1
(en)
|
2013-06-14 |
2014-12-18 |
Gilead Sciences, Inc. |
Phosphatidylinositol 3-kinase inhibitors
|
TR201807090T4
(tr)
|
2013-07-25 |
2018-06-21 |
Janssen Sciences Ireland Uc |
Glioksamid sübstitüeli pirrolamid deriveleri ve bunun hepatitin tedavisine yönelik ilaçlar olarak kullanımı.
|
MX368625B
(es)
|
2013-07-30 |
2019-10-08 |
Janssen Sciences Ireland Uc |
Derivados de tieno[3,2-d]pirimidinas para el tratamiento de infecciones virales.
|
EP3030322A2
(en)
|
2013-08-05 |
2016-06-15 |
Cambridge Enterprise Limited |
Inhibition of cxcr4 signaling in cancer immunotherapy
|
WO2015023958A1
(en)
|
2013-08-15 |
2015-02-19 |
The University Of Kansas |
Toll-like receptor agonists
|
AU2014315457B2
(en)
|
2013-09-04 |
2018-05-10 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
EP3041828B1
(en)
|
2013-09-06 |
2018-05-23 |
Aurigene Discovery Technologies Limited |
1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators
|
CA2922607C
(en)
|
2013-09-06 |
2022-08-30 |
Aurigene Discovery Technologies Limited |
1,2,4-oxadiazole derivatives as immunomodulators
|
CN105813640A
(zh)
|
2013-09-06 |
2016-07-27 |
奥瑞基尼探索技术有限公司 |
作为免疫调节剂的环肽类化合物
|
WO2015036927A1
(en)
|
2013-09-10 |
2015-03-19 |
Aurigene Discovery Technologies Limited |
Immunomodulating peptidomimetic derivatives
|
EA031003B1
(ru)
|
2013-09-11 |
2018-10-31 |
Инсерм (Энститю Насьональ Де Ля Сантэ Э Де Ля Решерш Медикаль) |
Способы и фармацевтические композиции для лечения вызванных вирусом гепатита в инфекций
|
WO2015044900A1
(en)
|
2013-09-27 |
2015-04-02 |
Aurigene Discovery Technologies Limited |
Therapeutic immunomodulating compounds
|
EP3057964B1
(en)
|
2013-10-14 |
2019-12-04 |
Eisai R&D Management Co., Ltd. |
Selectively substituted quinoline compounds
|
KR102365952B1
(ko)
|
2013-10-14 |
2022-02-22 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
선택적으로 치환된 퀴놀린 화합물
|
WO2015059212A1
(en)
|
2013-10-23 |
2015-04-30 |
Janssen R&D Ireland |
Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
EA201690979A1
(ru)
|
2013-11-14 |
2016-08-31 |
Новира Терапьютикс, Инк. |
Производные азепана и способы лечения инфекций гепатита в
|
JP2016540013A
(ja)
|
2013-12-13 |
2016-12-22 |
武田薬品工業株式会社 |
Tlr阻害剤としてのピロロ[3,2−c]ピリジン誘導体
|
US10654807B2
(en)
|
2013-12-20 |
2020-05-19 |
The University Of Kansas |
Toll-like receptor 8 agonists
|
US9169212B2
(en)
|
2014-01-16 |
2015-10-27 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
US9181288B2
(en)
|
2014-01-16 |
2015-11-10 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
CA2931329A1
(en)
|
2014-01-30 |
2015-08-06 |
F. Hoffmann-La Roche Ag |
Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
|
SG10201806297VA
(en)
|
2014-02-04 |
2018-08-30 |
Incyte Corp |
Combination of a pd-1 antagonist and an ido1 inhibitor for treating cancer
|
CN110483484A
(zh)
|
2014-02-06 |
2019-11-22 |
爱尔兰詹森科学公司 |
氨磺酰基吡咯酰胺衍生物及其作为药物用于治疗乙型肝炎的用途
|
US20170088626A1
(en)
|
2014-03-05 |
2017-03-30 |
Bristol-Myers Squibb Company |
Treatment of renal cancer using a combination of an anti-pd-1 antibody and another anti-cancer agent
|
BR112016020566B1
(pt)
|
2014-03-07 |
2022-11-29 |
F. Hoffmann-La Roche Ag |
Novas heteroaril-diidro-pirimidinas fundidas na posição 6 para o tratamento e profilaxia da infecção pelo vírus da hepatite b
|
US9400280B2
(en)
|
2014-03-27 |
2016-07-26 |
Novira Therapeutics, Inc. |
Piperidine derivatives and methods of treating hepatitis B infections
|
US9850225B2
(en)
|
2014-04-14 |
2017-12-26 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
AR100137A1
(es)
|
2014-04-22 |
2016-09-14 |
Hoffmann La Roche |
Compuestos 4-amino-imidazoquinolina
|
CN106232603B
(zh)
|
2014-05-01 |
2019-07-05 |
诺华股份有限公司 |
作为toll-样受体7激动剂的化合物和组合物
|
EA032487B1
(ru)
|
2014-05-01 |
2019-06-28 |
Новартис Аг |
Соединения и композиции в качестве агонистов toll-подобного рецептора 7
|
CN106459032B
(zh)
|
2014-05-13 |
2019-04-05 |
豪夫迈·罗氏有限公司 |
治疗和预防乙型肝炎病毒感染的新的二氢喹嗪酮类
|
AU2015259470A1
(en)
*
|
2014-05-16 |
2016-11-10 |
Yale University |
Virus like vesicles (VLVs) based vaccines to prevent or treat chronic hepatitis B virus (HBV) infection
|
MA39906A
(fr)
|
2014-05-23 |
2017-03-01 |
Eisai R&D Man Co Ltd |
Polythérapies pour le traitement du cancer
|
WO2015183895A1
(en)
|
2014-05-27 |
2015-12-03 |
University Of Rochester |
Novel arenavirus vaccine
|
RU2016149812A
(ru)
|
2014-06-06 |
2018-07-17 |
Флексус Байосайенсиз, Инк. |
Иммунорегулирующие средства
|
WO2016012470A1
(en)
|
2014-07-25 |
2016-01-28 |
F. Hoffmann-La Roche Ag |
New amorphous and crystalline forms of (3s)-4-[[(4r)-4-(2-chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1, 4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic acid
|
US9943585B2
(en)
|
2014-07-30 |
2018-04-17 |
University Of Rochester |
Methods and compositions related to reorganization of arenavirus genome for development of novel arenavirus live-attenuated vaccines (LAV)
|
MX2017001154A
(es)
|
2014-08-01 |
2017-11-30 |
3M Innovative Properties Co |
Metodos y combinaciones terapeuticas para tratar tumores.
|
RU2664329C1
(ru)
|
2014-08-14 |
2018-08-16 |
Ф. Хоффманн-Ля Рош Аг |
Новые пиридазоны и триазиноны для лечения и профилактики заражения вирусом гепатита b
|
US9962388B2
(en)
|
2014-08-15 |
2018-05-08 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Pyrrolopyrimidine compounds used as TLR7 agonist
|
WO2016029077A1
(en)
|
2014-08-22 |
2016-02-25 |
Janus Biotherapeutics, Inc. |
Novel n2, n4, n7, 6-tetrasubstituted pteridine-2,4,7-triamine and 2, 4, 6, 7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
|
EA201790154A1
(ru)
|
2014-08-27 |
2017-08-31 |
Джилид Сайэнс, Инк. |
Соединения и способы для ингибирования гистоновых деметилаз
|
US9884866B2
(en)
|
2014-09-08 |
2018-02-06 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
EP3191113B1
(en)
|
2014-09-11 |
2019-11-06 |
Bristol-Myers Squibb Company |
Macrocyclic inhibitors of the pd-1/pd-l1 and cd80 (b7-1)/pd-l1 protein/protein interactions
|
WO2016057924A1
(en)
|
2014-10-10 |
2016-04-14 |
Genentech, Inc. |
Pyrrolidine amide compounds as histone demethylase inhibitors
|
US9732119B2
(en)
|
2014-10-10 |
2017-08-15 |
Bristol-Myers Squibb Company |
Immunomodulators
|
JP2017531655A
(ja)
|
2014-10-11 |
2017-10-26 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
感染性疾患の処置に使用するための化合物
|
US9637485B2
(en)
|
2014-11-03 |
2017-05-02 |
Hoffmann-La Roche Inc. |
6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection
|
UY36390A
(es)
|
2014-11-05 |
2016-06-01 |
Flexus Biosciences Inc |
Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
|
CN107223130A
(zh)
|
2014-11-13 |
2017-09-29 |
日内瓦大学 |
作为疫苗载体的三片段沙粒病毒
|
MX2017006302A
(es)
|
2014-11-13 |
2018-02-16 |
Glaxosmithkline Biologicals Sa |
Derivados de adenina que son utiles en el tratamiento de enfermedades alergicas u otras afecciones inflamatorias.
|
US9856292B2
(en)
|
2014-11-14 |
2018-01-02 |
Bristol-Myers Squibb Company |
Immunomodulators
|
DK3230298T3
(da)
|
2014-12-08 |
2021-03-22 |
Hoffmann La Roche |
3-substituerede 5-amino-6H-thiazolo[4,5-d]pyrimidin-2,7-dion forbindelser til behandling og forebyggelse af virusinfektion
|
WO2016090470A1
(en)
|
2014-12-08 |
2016-06-16 |
Brian Chen |
Cleavable nucleic acid linkers for protein quantification ratioing
|
US9861680B2
(en)
|
2014-12-18 |
2018-01-09 |
Bristol-Myers Squibb Company |
Immunomodulators
|
CN107148417B
(zh)
|
2014-12-18 |
2020-09-08 |
豪夫迈·罗氏有限公司 |
苯并氮杂*磺酰胺化合物
|
US9944678B2
(en)
|
2014-12-19 |
2018-04-17 |
Bristol-Myers Squibb Company |
Immunomodulators
|
US9676793B2
(en)
|
2014-12-23 |
2017-06-13 |
Hoffmann-Laroche Inc. |
Co-crystals of 5-amino-2-oxothiazolo[4,5-d]pyrimidin-3(2H)-yl-5-hydroxymethyl tetrahydrofuran-3-yl acetate and methods for preparing and using the same
|
AR103222A1
(es)
|
2014-12-23 |
2017-04-26 |
Hoffmann La Roche |
Procedimiento para la preparación de análogos de 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidina
|
CN105732635A
(zh)
|
2014-12-29 |
2016-07-06 |
南京明德新药研发股份有限公司 |
一类Toll样受体7激动剂
|
CN107108610B
(zh)
|
2014-12-30 |
2019-06-04 |
豪夫迈·罗氏有限公司 |
用于治疗和预防肝炎b病毒感染的新的四氢吡啶并嘧啶和四氢吡啶并吡啶化合物
|
CN107531691A
(zh)
|
2014-12-30 |
2018-01-02 |
诺维拉治疗公司 |
治疗乙型肝炎感染的衍生物和方法
|
CN107109497A
(zh)
|
2014-12-31 |
2017-08-29 |
豪夫迈·罗氏有限公司 |
通过实时PCR从细胞裂解物定量HBV cccDNA的高通量新方法
|
MA41338B1
(fr)
|
2015-01-16 |
2019-07-31 |
Hoffmann La Roche |
Composés de pyrazine pour le traitement de maladies infectieuses
|
WO2016120186A1
(en)
|
2015-01-27 |
2016-08-04 |
F. Hoffmann-La Roche Ag |
Recombinant hbv cccdna, the method to generate thereof and the use thereof
|
WO2016128335A1
(en)
|
2015-02-11 |
2016-08-18 |
F. Hoffmann-La Roche Ag |
Novel 2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis b virus infection
|
EP3256156A1
(en)
*
|
2015-02-13 |
2017-12-20 |
Transgene SA |
Immunotherapeutic vaccine and antibody combination therapy
|
MD20170081A2
(ro)
|
2015-03-04 |
2018-03-31 |
Gilead Sciences, Inc. |
Compuşi 4,6-diamino-pirido[3,2-D]pirimidină modulatori ai receptorilor de tip Toll
|
HUE042563T2
(hu)
|
2015-03-06 |
2019-07-29 |
Hoffmann La Roche |
Benzazepin-dikarboxamid vegyületek
|
KR20170123680A
(ko)
|
2015-03-10 |
2017-11-08 |
오리진 디스커버리 테크놀로지스 리미티드 |
면역조절제로서의 1,3,4-옥사다이아졸 및 티아다이아졸 화합물
|
WO2016142835A1
(en)
|
2015-03-10 |
2016-09-15 |
Aurigene Discovery Technologies Limited |
Therapeutic cyclic compounds as immunomodulators
|
CN107427497A
(zh)
|
2015-03-10 |
2017-12-01 |
奥瑞基尼探索技术有限公司 |
作为免疫调节剂的3‑取代的1,3,4‑噁二唑和噻二唑化合物
|
CA2979161A1
(en)
|
2015-03-10 |
2016-09-15 |
Aurigene Discovery Technologies Limited |
3-substituted-1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
|
WO2016142833A1
(en)
|
2015-03-10 |
2016-09-15 |
Aurigene Discovery Technologies Limited |
1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
|
US9809625B2
(en)
|
2015-03-18 |
2017-11-07 |
Bristol-Myers Squibb Company |
Immunomodulators
|
US10442788B2
(en)
|
2015-04-01 |
2019-10-15 |
Enanta Pharmaceuticals, Inc. |
Hepatitis B antiviral agents
|
WO2016168619A1
(en)
|
2015-04-17 |
2016-10-20 |
Indiana University Research And Technology Corporation |
Hepatitis b viral assembly effectors
|
WO2016177655A1
(en)
|
2015-05-04 |
2016-11-10 |
F. Hoffmann-La Roche Ag |
Tetrahydropyridopyrimidines and tetrahydropyridopyridines as inhibitors of hbsag (hbv surface antigen) and hbv dna production for the treatment of hepatitis b virus infections
|
EP3292152A1
(en)
|
2015-05-07 |
2018-03-14 |
Agenus Inc. |
Anti-ox40 antibodies and methods of use thereof
|
EP3294746B1
(en)
|
2015-05-12 |
2021-10-06 |
F. Hoffmann-La Roche AG |
Substituted aminothiazolopyrimidinedione derivatives for the treatment and prophylaxis of virus infection
|
KR20180026670A
(ko)
*
|
2015-05-26 |
2018-03-13 |
어드박시스, 인크. |
맞춤형 전달 벡터-기반의 면역 요법 및 이의 용도
|
US10196701B2
(en)
|
2015-06-01 |
2019-02-05 |
The Penn State Research Foundation |
Hepatitis B virus capsid assembly
|
US20160376864A1
(en)
|
2015-06-29 |
2016-12-29 |
Cameron International Corporation |
Apparatus and method for distributing fluids to a wellbore
|
WO2017001307A1
(en)
|
2015-06-30 |
2017-01-05 |
F. Hoffmann-La Roche Ag |
Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
|
GB201511477D0
(en)
|
2015-06-30 |
2015-08-12 |
Redx Pharma Plc |
Antiviral compounds
|
US10875876B2
(en)
|
2015-07-02 |
2020-12-29 |
Janssen Sciences Ireland Uc |
Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
|
WO2017007701A1
(en)
|
2015-07-07 |
2017-01-12 |
Merck Sharp & Dohme Corp. |
Antiviral phosphodiamide compounds
|
CN107849037B
(zh)
|
2015-07-21 |
2020-04-17 |
豪夫迈·罗氏有限公司 |
用于治疗和预防乙型肝炎病毒感染的三环4-吡啶酮-3-甲酸衍生物
|
GB201513010D0
(en)
|
2015-07-23 |
2015-09-09 |
Glaxosmithkline Biolog Sa |
Novel formulation
|
WO2017016960A1
(en)
|
2015-07-24 |
2017-02-02 |
F. Hoffmann-La Roche Ag |
Process for the preparation of (6s)-6-alkyl-10-alkoxy-9-(substituted alkoxy)-2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid analogues
|
EP3328855B1
(en)
|
2015-07-27 |
2019-05-15 |
H. Hoffnabb-La Roche Ag |
Novel tetracyclic 4-oxo-pyridine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis b virus infection
|
JP6559324B2
(ja)
|
2015-07-28 |
2019-08-14 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
B型肝炎ウイルス感染の治療及び予防用の新規6,7−ジヒドロピリド[2,1−a]フタラジン−2−オン類
|
CN108235685A
(zh)
|
2015-07-29 |
2018-06-29 |
诺华股份有限公司 |
Pd-1拮抗剂与egfr抑制剂的组合
|
TN2018000048A1
(en)
|
2015-08-10 |
2019-07-08 |
Merck Sharp & Dohme |
Antiviral beta-amino acid ester phosphodiamide compounds
|
UA123701C2
(uk)
|
2015-08-13 |
2021-05-19 |
Мерк Шарп І Доум Корп. |
Циклічні динуклеотидні сполуки як агоністи sting
|
WO2017034986A1
(en)
|
2015-08-21 |
2017-03-02 |
University Of Kansas |
Human tlr8-selective agonists
|
WO2017038909A1
(en)
|
2015-08-28 |
2017-03-09 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compounds
|
US10150768B2
(en)
|
2015-08-31 |
2018-12-11 |
3M Innovative Properties Company |
Guanidine substituted imidazo[4,5-c] ring compounds
|
WO2017040815A1
(en)
|
2015-09-04 |
2017-03-09 |
Tocagen Inc. |
Recombinant vectors comprising 2a peptide
|
TWI730985B
(zh)
|
2015-09-15 |
2021-06-21 |
美商艾森伯利生物科學公司 |
B型肝炎核心蛋白質調節劑
|
JP2018527366A
(ja)
|
2015-09-15 |
2018-09-20 |
ギリアード サイエンシーズ, インコーポレイテッド |
HIVを処置するためのtoll様レセプターのモジュレーター
|
WO2017046112A1
(en)
|
2015-09-17 |
2017-03-23 |
F. Hoffmann-La Roche Ag |
Sulfinylphenyl or sulfonimidoylphenyl benzazepines
|
JP6856900B2
(ja)
|
2015-09-17 |
2021-04-14 |
国立大学法人富山大学 |
トール様受容体7またはトール様受容体9の活性化阻害剤
|
JP6723254B2
(ja)
|
2015-10-05 |
2020-07-15 |
富士フイルム富山化学株式会社 |
抗b型肝炎ウイルス剤
|
JP6769976B2
(ja)
|
2015-10-07 |
2020-10-14 |
大日本住友製薬株式会社 |
ピリミジン化合物
|
US10745382B2
(en)
|
2015-10-15 |
2020-08-18 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
MA52119A
(fr)
|
2015-10-19 |
2018-08-29 |
Ncyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
MX2018005299A
(es)
|
2015-10-28 |
2019-03-18 |
Aduro Biotech Inc |
Composiciones y métodos para activar la señalización dependiente del "estimulador del gen de interferon".
|
CN108779472B
(zh)
*
|
2015-11-04 |
2022-09-09 |
霍欧奇帕生物科技有限公司 |
针对乙型肝炎病毒的疫苗
|
CA3004083A1
(en)
|
2015-11-04 |
2017-05-11 |
Incyte Corporation |
Pharmaceutical compositions and methods for indoleamine 2,3-dioxygenase inhibition and indications therefor
|
MY189991A
(en)
|
2015-11-05 |
2022-03-22 |
Chia Tai Tianqing Pharmaceutical Group Co Ltd |
7-(thiazol-5-yl)pyrrolopyrimidine compound as tlr7 agonist
|
SG11201804152RA
(en)
|
2015-11-19 |
2018-06-28 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
CA3005855A1
(en)
|
2015-11-19 |
2017-05-26 |
Bristol-Myers Squibb Company |
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereof
|
WO2017096276A1
(en)
|
2015-12-02 |
2017-06-08 |
Agenus Inc. |
Anti-gitr antibodies and methods of use thereof
|
EP3383431A4
(en)
|
2015-12-02 |
2019-08-28 |
Agenus Inc. |
ANTI-GITR ANTIBODIES AND METHOD OF USE THEREOF
|
JP7089470B2
(ja)
|
2015-12-02 |
2022-06-22 |
アジェナス インコーポレイテッド |
抗体およびその使用方法
|
MA43389A
(fr)
|
2015-12-02 |
2021-05-12 |
Agenus Inc |
Anticorps anti-ox40 et leurs procédés d'utilisation
|
RU2722019C2
(ru)
|
2015-12-03 |
2020-05-26 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Циклические пуриновые динуклеотиды в качестве модуляторов sting
|
AU2016364891A1
(en)
|
2015-12-03 |
2018-06-07 |
Agenus Inc. |
Anti-OX40 antibodies and methods of use thereof
|
WO2017100108A1
(en)
|
2015-12-10 |
2017-06-15 |
Merck Sharp & Dohme Corp. |
Antiviral phosphodiamide prodrugs of tenofovir
|
WO2017106740A1
(en)
|
2015-12-16 |
2017-06-22 |
Aduro Biotech, Inc. |
Methods for identifying inhibitors of "stimulator of interferon gene"-dependent interferon production
|
WO2017106607A1
(en)
|
2015-12-17 |
2017-06-22 |
Merck Patent Gmbh |
Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders
|
TW201726623A
(zh)
|
2015-12-17 |
2017-08-01 |
英塞特公司 |
作為免疫調節劑之雜環化合物
|
ES2844374T3
(es)
|
2015-12-22 |
2021-07-22 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
US10905760B2
(en)
|
2016-01-28 |
2021-02-02 |
Svenska Vaccinfabriken Produktion Ab |
Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines containing hepatitis B virus genes
|
US9845325B2
(en)
|
2016-02-19 |
2017-12-19 |
Novartis Ag |
Tetracyclic pyridone compounds as antivirals
|
CA3017524A1
(en)
|
2016-03-18 |
2017-09-21 |
Immune Sensor, Llc |
Cyclic di-nucleotide compounds and methods of use
|
US10662177B2
(en)
|
2016-03-21 |
2020-05-26 |
Council Of Scientific & Industrial Research |
Blocking toll-like receptor 9 signaling with small molecule antagonist
|
US10358463B2
(en)
|
2016-04-05 |
2019-07-23 |
Bristol-Myers Squibb Company |
Immunomodulators
|
US10533007B2
(en)
|
2016-04-19 |
2020-01-14 |
Innate Tumor Immunity, Inc. |
NLRP3 modulators
|
US10556903B2
(en)
|
2016-04-19 |
2020-02-11 |
Innate Tumor Immunity, Inc. |
NLRP3 modulators
|
WO2017186711A1
(en)
|
2016-04-25 |
2017-11-02 |
Invivogen |
Novel complexes of immunostimulatory compounds, and uses thereof
|
SI3453707T1
(sl)
|
2016-05-06 |
2022-04-29 |
Shanghai De Novo Pharmatech Co., Ltd. |
Benzazepinski derivati, postopek priprave, farmacevtski sestavek in uporaba le-teh
|
EP3452476B1
(en)
|
2016-05-06 |
2021-12-15 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
EP3458593A1
(en)
|
2016-05-18 |
2019-03-27 |
Hookipa Biotech GmbH |
Tri-segmented pichinde viruses as vaccine vectors
|
JP6957518B2
(ja)
|
2016-05-20 |
2021-11-02 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
感染症の治療のための酸素、硫黄および窒素リンカーを有する新規ピラジン化合物
|
WO2017202704A1
(en)
|
2016-05-23 |
2017-11-30 |
F. Hoffmann-La Roche Ag |
Benzazepine dicarboxamide compounds with tertiary amide function
|
EP3464274B1
(en)
|
2016-05-23 |
2020-05-27 |
H. Hoffnabb-La Roche Ag |
Benzazepine dicarboxamide compounds with secondary amide function
|
TW201808902A
(zh)
|
2016-05-26 |
2018-03-16 |
美商英塞特公司 |
作為免疫調節劑之雜環化合物
|
JP6957522B2
(ja)
|
2016-05-26 |
2021-11-02 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
B型肝炎ウイルス疾患の治療および予防のためのキサントン誘導体
|
WO2017211791A1
(en)
|
2016-06-07 |
2017-12-14 |
F. Hoffmann-La Roche Ag |
Combination therapy of an hbsag inhibitor and a tlr7 agonist
|
WO2017214395A1
(en)
|
2016-06-10 |
2017-12-14 |
Enanta Pharmaceuticals, Inc. |
Hepatitis b antiviral agents
|
JP7012668B2
(ja)
|
2016-06-12 |
2022-02-14 |
エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト |
ジヒドロピリミジニルベンズアゼピンジカルボキサミド化合物
|
WO2017216685A1
(en)
|
2016-06-16 |
2017-12-21 |
Novartis Ag |
Pentacyclic pyridone compounds as antivirals
|
WO2017216686A1
(en)
|
2016-06-16 |
2017-12-21 |
Novartis Ag |
8,9-fused 2-oxo-6,7-dihydropyrido-isoquinoline compounds as antivirals
|
ES2927984T3
(es)
|
2016-06-20 |
2022-11-14 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
WO2017219931A1
(zh)
|
2016-06-22 |
2017-12-28 |
四川科伦博泰生物医药股份有限公司 |
二氢蝶啶酮类衍生物、其制备方法及其用途
|
GB2549809C
(en)
|
2016-06-23 |
2022-11-30 |
Univ Oxford Innovation Ltd |
Vector
|
CN109311880B
(zh)
|
2016-06-29 |
2021-09-03 |
豪夫迈·罗氏有限公司 |
用于治疗和预防乙型肝炎病毒感染的新的四氢吡啶并嘧啶类化合物
|
CA3029566A1
(en)
|
2016-06-29 |
2018-01-04 |
Novira Therapeutics, Inc. |
Diazepinone derivatives and their use in the treatment of hepatitis b infections
|
WO2018005881A1
(en)
|
2016-06-29 |
2018-01-04 |
Novira Therapeutics, Inc. |
Oxadiazepinone derivatives and their use in the treatment of hepatitis b infections
|
JP6821716B2
(ja)
|
2016-06-29 |
2021-01-27 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
B型肝炎ウイルス感染の処置および予防のための新規のジヒドロピロロピリミジン
|
US10071079B2
(en)
|
2016-06-29 |
2018-09-11 |
Bristol-Myers Squibb Company |
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
|
KR102468272B1
(ko)
|
2016-06-30 |
2022-11-18 |
삼성전자주식회사 |
음향 출력 장치 및 그 제어 방법
|
WO2018002319A1
(en)
|
2016-07-01 |
2018-01-04 |
Janssen Sciences Ireland Uc |
Dihydropyranopyrimidines for the treatment of viral infections
|
JP6301402B2
(ja)
|
2016-07-01 |
2018-03-28 |
日新製鋼株式会社 |
フェライト系ステンレス鋼板およびその製造方法
|
WO2018009466A1
(en)
|
2016-07-05 |
2018-01-11 |
Aduro Biotech, Inc. |
Locked nucleic acid cyclic dinucleotide compounds and uses thereof
|
AU2017292758A1
(en)
|
2016-07-08 |
2019-02-21 |
Bristol-Myers Squibb Company |
1,3-dihydroxy-phenyl derivatives useful as immunomodulators
|
CN109415368B
(zh)
|
2016-07-14 |
2021-04-30 |
豪夫迈·罗氏有限公司 |
用于治疗感染性疾病的羧基6,7-二氢-4H-吡唑并[1,5-a]吡嗪化合物
|
EP3484883B1
(en)
|
2016-07-14 |
2020-04-15 |
H. Hoffnabb-La Roche Ag |
Novel tetrahydropyrazolopyridine compounds for the treatment of infectious diseases
|
ES2930092T3
(es)
|
2016-07-14 |
2022-12-07 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
EP3484886B1
(en)
|
2016-07-14 |
2020-03-04 |
Hoffmann-La Roche AG |
6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine and 6,7-dihydro-4h-triazolo[1,5-a]pyrazine compounds for the treatment of infectious diseases
|
WO2018011160A1
(en)
|
2016-07-14 |
2018-01-18 |
F. Hoffmann-La Roche Ag |
6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine compounds for the treatment of infectious diseases
|
WO2018022282A1
(en)
|
2016-07-29 |
2018-02-01 |
Newave Pharmaceutical Inc. |
Novel therapeutic agents for the treatment of hbv infection
|
WO2018019297A1
(zh)
|
2016-07-29 |
2018-02-01 |
银杏树药业(苏州)有限公司 |
异喹啉酮类化合物及其制备抗病毒药物的应用
|
CN109715617B
(zh)
|
2016-07-30 |
2022-04-19 |
百时美施贵宝公司 |
作为tlr7、tlr8或tlr9抑制剂的二甲氧基苯基取代的吲哚化合物
|
CN109195602B
(zh)
|
2016-08-03 |
2022-01-07 |
上海齐鲁制药研究中心有限公司 |
用作免疫调节剂的对称或半对称化合物
|
EP3503894A1
(en)
|
2016-08-24 |
2019-07-03 |
H. Hoffnabb-La Roche Ag |
Combination therapy of an hbv capsid assembly inhibitor and a nucleos(t)ide analogue
|
JOP20190024A1
(ar)
|
2016-08-26 |
2019-02-19 |
Gilead Sciences Inc |
مركبات بيروليزين بها استبدال واستخداماتها
|
CA3034553A1
(en)
|
2016-08-26 |
2018-03-01 |
3M Innovative Properties Company |
Fused [1,2]imidazo[4,5-c] ring compounds substituted with guanidino groups
|
ES2941716T3
(es)
|
2016-08-29 |
2023-05-25 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
US10144706B2
(en)
|
2016-09-01 |
2018-12-04 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
US10640499B2
(en)
|
2016-09-02 |
2020-05-05 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|
CA3035346A1
(en)
|
2016-09-02 |
2018-03-08 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|
WO2018043747A1
(ja)
|
2016-09-05 |
2018-03-08 |
国立大学法人京都大学 |
抗b型肝炎ウイルス剤
|
BE1024865B1
(fr)
|
2016-09-07 |
2018-07-31 |
Glaxosmithkline Biologicals Sa |
Derives d'imidazoquinoleine
|
WO2018045911A1
(zh)
|
2016-09-09 |
2018-03-15 |
浙江海正药业股份有限公司 |
二氢嘧啶类化合物及其制备方法和用途
|
KR102411532B1
(ko)
|
2016-09-09 |
2022-06-22 |
노파르티스 아게 |
엔도솜 톨-유사 수용체의 억제제로서의 화합물 및 조성물
|
US10660877B2
(en)
|
2016-09-09 |
2020-05-26 |
Bristol-Myers Squibb Company |
Pyridyl substituted indole compounds
|
WO2018051254A1
(en)
|
2016-09-14 |
2018-03-22 |
Aurigene Discovery Technologies Limited |
Cyclic substituted-1,2,4-oxadiazole compounds as immunomodulators
|
WO2018051255A1
(en)
|
2016-09-14 |
2018-03-22 |
Aurigene Discovery Technologies Limited |
Cyclic substituted-1,3,4-oxadiazole and thiadiazole compounds as immunomodulators
|
US10537590B2
(en)
|
2016-09-30 |
2020-01-21 |
Boehringer Ingelheim International Gmbh |
Cyclic dinucleotide compounds
|
BR112019006816A8
(pt)
|
2016-10-04 |
2023-02-07 |
Merck Sharp & Dohme |
Compostos de benzo[b]tiofeno como agonistas de sting, composição farmacêutica e uso dos mesmos
|
WO2018065360A1
(de)
|
2016-10-07 |
2018-04-12 |
Biolog Life Science Institute Forschungslabor Und Biochemica-Vertrieb Gmbh |
Benzimidazolhaltige cyclische dinukleotide, verfahren zu deren herstellung und ihre verwendung zur aktivierung von stimulator von interferongenen (sting)-abhängigen signalwegen
|
IL265921B2
(en)
|
2016-10-14 |
2024-05-01 |
Prec Biosciences Inc |
Transgenic meganonucleases specific for recognition sequences in the hepatitis B virus genome
|
CN110139856A
(zh)
|
2016-10-20 |
2019-08-16 |
奥列基因发现技术有限公司 |
Vista和pd-1通路的双重抑制剂
|
EP3532069A4
(en)
|
2016-10-26 |
2020-05-13 |
Merck Sharp & Dohme Corp. |
ARYL-AMIDE PHOSPHODIAMIDE COMPOUNDS ANTIVIRALS
|
WO2018078149A1
(en)
|
2016-10-31 |
2018-05-03 |
F. Hoffmann-La Roche Ag |
Novel cyclicsulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
|
ES2910832T3
(es)
|
2016-11-07 |
2022-05-13 |
Bristol Myers Squibb Co |
Inmunomoduladores
|
EP3538152A4
(en)
|
2016-11-09 |
2020-09-30 |
Agenus Inc. |
ANTI-OX40 ANTIBODIES, ANTI-GITR ANTIBODIES AND METHOD OF USING THEREOF
|
US11084818B2
(en)
|
2016-11-11 |
2021-08-10 |
Hepo Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic compound, preparation method, intermediate, pharmaceutical composition and use
|
US11370794B2
(en)
|
2016-11-11 |
2022-06-28 |
Dynavax Technologies Corporation |
Toll-like receptor antagonist compounds and methods of use
|
JOP20170188A1
(ar)
|
2016-11-25 |
2019-01-30 |
Janssen Biotech Inc |
ثنائي النوكليوتيدات الحلقية كمنبهات ستينغ (sting)
|
HUE054964T2
(hu)
|
2016-11-28 |
2021-10-28 |
Jiangsu Hengrui Medicine Co |
Pirazol-heteroaril készítmény, az elõállítás módja és gyógyászati felhasználása
|
JOP20170192A1
(ar)
|
2016-12-01 |
2019-01-30 |
Takeda Pharmaceuticals Co |
داي نوكليوتيد حلقي
|
RU2019122598A
(ru)
|
2016-12-20 |
2021-01-22 |
Мерк Шарп И Доум Корп. |
Циклические динуклеотидные агонисты sting для лечения рака
|
WO2018118848A1
(en)
|
2016-12-20 |
2018-06-28 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
RU2019122602A
(ru)
|
2016-12-20 |
2021-01-22 |
Мерк Шарп И Доум Корп. |
Комбинации антагонистов pd-1 и циклических динуклеотидных агонистов sting для лечения рака
|
MX2019007262A
(es)
|
2016-12-22 |
2019-09-05 |
Merck Sharp & Dohme |
Compuestos antivirales de bencilamina fosfodiamida.
|
EP3558985B1
(en)
|
2016-12-22 |
2022-09-07 |
Incyte Corporation |
Benzooxazole derivatives as immunomodulators
|
US20180179202A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
US20180179179A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
WO2018119263A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds derivatives as pd-l1 internalization inducers
|
ES2874756T3
(es)
|
2016-12-22 |
2021-11-05 |
Incyte Corp |
Derivados de triazolo[1,5-A]piridina como inmunomoduladores
|
MX2019007585A
(es)
|
2016-12-22 |
2019-09-09 |
Merck Sharp & Dohme |
Profarmacos de ester alifatico antiviricos de tenofovir.
|
GB201705765D0
(en)
*
|
2017-04-10 |
2017-05-24 |
Univ Oxford Innovation Ltd |
HBV vaccine
|
JOP20180040A1
(ar)
|
2017-04-20 |
2019-01-30 |
Gilead Sciences Inc |
مثبطات pd-1/pd-l1
|
JP2021500880A
(ja)
|
2017-10-16 |
2021-01-14 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
2つの発現カセットを有するサルアデノウイルスベクター
|
JP2020537525A
(ja)
|
2017-10-16 |
2020-12-24 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
複製能力のあるアデノウイルスベクター
|
GB201721068D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Biologicals Sa |
Hepatitis B immunisation regimen and compositions
|
GB201721069D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Biologicals Sa |
Hepatitis B Immunisation regimen and compositions
|
US11020476B2
(en)
|
2017-12-19 |
2021-06-01 |
Janssen Sciences Ireland Unlimited Company |
Methods and compositions for inducing an immune response against Hepatitis B Virus (HBV)
|
US11021692B2
(en)
*
|
2017-12-19 |
2021-06-01 |
Janssen Sciences Ireland Unlimited Company |
Hepatitis B virus (HBV) vaccines and uses thereof
|
CN112313339A
(zh)
|
2018-01-05 |
2021-02-02 |
渥太华医院研究所 |
修饰的牛痘载体
|
AU2019222644B2
(en)
|
2018-02-13 |
2021-04-01 |
Gilead Sciences, Inc. |
PD-1/PD-L1 inhibitors
|
US11142750B2
(en)
|
2018-04-12 |
2021-10-12 |
Precision Biosciences, Inc. |
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
|
JP7105359B2
(ja)
|
2018-07-13 |
2022-07-22 |
ギリアード サイエンシーズ, インコーポレイテッド |
Pd-1/pd-l1阻害剤
|
CA3143421A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Arenavirus vectors for hepatitis b virus (hbv) vaccines and uses thereof
|
EP4021923A1
(en)
|
2019-08-29 |
2022-07-06 |
VIR Biotechnology, Inc. |
Hepatitis b virus vaccines
|
WO2021067181A1
(en)
|
2019-09-30 |
2021-04-08 |
Gilead Sciences, Inc. |
Hbv vaccines and methods treating hbv
|